211 related articles for article (PubMed ID: 14693779)
21. [Inactive Graves' ophthalmopathy and self-esteem].
Magalhães CH; Pereira MD; Manso PG; Veiga DF; Novo NF; Ferreira LM
Arq Bras Oftalmol; 2008; 71(2):215-20. PubMed ID: 18516421
[TBL] [Abstract][Full Text] [Related]
22. Psychosocial morbidity of Graves' orbitopathy.
Kahaly GJ; Petrak F; Hardt J; Pitz S; Egle UT
Clin Endocrinol (Oxf); 2005 Oct; 63(4):395-402. PubMed ID: 16181231
[TBL] [Abstract][Full Text] [Related]
23. The Psychosocial and Clinical Outcomes of Orbital Decompression Surgery for Thyroid Eye Disease and Predictors of Change in Quality of Life.
Wickwar S; McBain H; Ezra DG; Hirani SP; Rose GE; Newman SP
Ophthalmology; 2015 Dec; 122(12):2568-76.e1. PubMed ID: 26421706
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of quality of life in patients with Graves orbitopathy and its influencing factors].
Weng CY; Li ZF; Hu SD; Luo YS; Feng XT; Zhong Q; Zhang Q; Shen J
Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):577-583. PubMed ID: 31365979
[No Abstract] [Full Text] [Related]
25. Assessment of quality of life and depression in Korean patients with Graves' ophthalmopathy.
Lee H; Roh HS; Yoon JS; Lee SY
Korean J Ophthalmol; 2010 Apr; 24(2):65-72. PubMed ID: 20379454
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of Graves' ophthalmopathy on health-related quality of life.
Terwee C; Wakelkamp I; Tan S; Dekker F; Prummel MF; Wiersinga W
Eur J Endocrinol; 2002 Jun; 146(6):751-7. PubMed ID: 12039694
[TBL] [Abstract][Full Text] [Related]
27. Graves' ophthalmopathy: the clinical and psychosocial outcomes of different medical interventions - a systematic review.
Bello OM; Druce M; Ansari E
BMJ Open Ophthalmol; 2024 Jun; 9(1):. PubMed ID: 38886120
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in a german graves orbitopathy population.
Ponto KA; Hommel G; Pitz S; Elflein H; Pfeiffer N; Kahaly GJ
Am J Ophthalmol; 2011 Sep; 152(3):483-490.e1. PubMed ID: 21676374
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation by quality of life questionnaires in patients undergoing strabismus surgery in Graves' disease].
Schaut A; Cloché V; Mouna A; Angioi K; Berrod JP; Conart JB; Maalouf T
J Fr Ophtalmol; 2018 Nov; 41(9):814-822. PubMed ID: 30217613
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of disease-specific quality of life and its influencing factors in Bulgarian patients with Graves' orbitopathy.
Stoynova MA; Shinkov AD; Dimitrova ID; Yankova IA; Kovatcheva RD
Int Ophthalmol; 2024 Feb; 44(1):68. PubMed ID: 38347322
[TBL] [Abstract][Full Text] [Related]
31. Quality of life improves after strabismus surgery in patients with Graves' orbitopathy.
Jellema HM; Merckel-Timmer E; Kloos R; Saeed P; Mourits MP
Eur J Endocrinol; 2014 May; 170(5):785-9. PubMed ID: 24493116
[TBL] [Abstract][Full Text] [Related]
32. [The influence factors of quality-of-life in patients with thyroid-associated ophthalmopathy].
Shen L; Zhu H; Li XX; Liu DD; Chen XY; Liu H
Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):575-582. PubMed ID: 28851197
[No Abstract] [Full Text] [Related]
33. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.
Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA
Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035
[TBL] [Abstract][Full Text] [Related]
34. Graves' ophthalmopathy: natural history and treatment outcomes.
Noth D; Gebauer M; Müller B; Bürgi U; Diem P
Swiss Med Wkly; 2001 Oct; 131(41-42):603-9. PubMed ID: 11820071
[TBL] [Abstract][Full Text] [Related]
35. Assessing the quality of life in Indian Graves' orbitopathy patients and validation of Hindi version of GO-QOL questionnaire.
Delampady K; Reddy SVB; Yadav SB
Indian J Ophthalmol; 2020 Aug; 68(8):1617-1621. PubMed ID: 32709791
[TBL] [Abstract][Full Text] [Related]
36. GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy.
Sawicka-Gutaj N; Bednarczuk T; Daroszewski J; Waligórska-Stachura J; Miśkiewicz P; Sowiński J; Bolanowski M; Ruchała M
Endokrynol Pol; 2015; 66(4):362-6. PubMed ID: 26323474
[TBL] [Abstract][Full Text] [Related]
37. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
[TBL] [Abstract][Full Text] [Related]
38. Objective and subjective outcomes of strabismus surgery in Graves' orbitopathy: a prospective multicentre study.
Jellema HM; Saeed P; Mombaerts I; Dolman PJ; Garrity J; Kazim M; Dhrami-Gavazi E; Lyons C; Nieuwkerk P; Mourits MP
Acta Ophthalmol; 2017 Jun; 95(4):386-391. PubMed ID: 28133945
[TBL] [Abstract][Full Text] [Related]
39. Change in quality of life after medical and surgical treatment of graves' ophthalmopathy.
Kashkouli MB; Heidari I; Pakdel F; Jam S; Honarbakhsh Y; Mirarmandehi B
Middle East Afr J Ophthalmol; 2011 Jan; 18(1):42-7. PubMed ID: 21572733
[TBL] [Abstract][Full Text] [Related]
40. A survey of the young person's experience of Graves' disease and its management.
Lane LC; Rankin J; Cheetham T
Clin Endocrinol (Oxf); 2021 Feb; 94(2):330-340. PubMed ID: 33128233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
